Ashley Wood
Directeur Technique/Scientifique/R&D chez ZOMEDICA CORP.
Profil
Ashley Wood is currently the Director of Research and Development at Zomedica Corp.
Prior to this, Wood was the Head of Research and Development at Swift Biosciences, Inc. and an Assistant Professor at Feinberg School of Medicine.
Wood received an undergraduate degree from Duke University and a doctorate from The Johns Hopkins University.
Postes actifs de Ashley Wood
| Sociétés | Poste | Début |
|---|---|---|
| ZOMEDICA CORP. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Ashley Wood
| Sociétés | Poste | Fin |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Directeur Technique/Scientifique/R&D | - |
| Feinberg School of Medicine | Corporate Officer/Principal | - |
Formation de Ashley Wood
| Duke University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZOMEDICA CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Health Technology |
